nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0372	0.069	CcSEcCtD
Dinoprost Tromethamine—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.0357	0.0662	CcSEcCtD
Dinoprost Tromethamine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0209	0.0388	CcSEcCtD
Dinoprost Tromethamine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0193	0.0358	CcSEcCtD
Dinoprost Tromethamine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0188	0.0348	CcSEcCtD
Dinoprost Tromethamine—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0327	CcSEcCtD
Dinoprost Tromethamine—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0327	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.0162	0.03	CcSEcCtD
Dinoprost Tromethamine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0135	0.0251	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0247	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0247	CcSEcCtD
Dinoprost Tromethamine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0238	CcSEcCtD
Dinoprost Tromethamine—PTGIR—hindbrain—amyotrophic lateral sclerosis	0.0127	0.0764	CbGeAlD
Dinoprost Tromethamine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0216	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0214	CcSEcCtD
Dinoprost Tromethamine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0208	CcSEcCtD
Dinoprost Tromethamine—GALR3—cerebellum—amyotrophic lateral sclerosis	0.0112	0.0673	CbGeAlD
Dinoprost Tromethamine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0206	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0197	CcSEcCtD
Dinoprost Tromethamine—HPGDS—embryo—amyotrophic lateral sclerosis	0.00974	0.0586	CbGeAlD
Dinoprost Tromethamine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00966	0.0179	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00918	0.017	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00898	0.0166	CcSEcCtD
Dinoprost Tromethamine—HPGDS—brainstem—amyotrophic lateral sclerosis	0.00892	0.0537	CbGeAlD
Dinoprost Tromethamine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00879	0.0163	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0145	CcSEcCtD
Dinoprost Tromethamine—PTGIR—brainstem—amyotrophic lateral sclerosis	0.00727	0.0438	CbGeAlD
Dinoprost Tromethamine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00723	0.0134	CcSEcCtD
Dinoprost Tromethamine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00713	0.0132	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0071	0.0132	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00702	0.013	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0068	0.0126	CcSEcCtD
Dinoprost Tromethamine—HPGDS—medulla oblongata—amyotrophic lateral sclerosis	0.00622	0.0375	CbGeAlD
Dinoprost Tromethamine—PTGER1—nervous system—amyotrophic lateral sclerosis	0.00617	0.0371	CbGeAlD
Dinoprost Tromethamine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00606	0.0112	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00603	0.0112	CcSEcCtD
Dinoprost Tromethamine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00599	0.0111	CcSEcCtD
Dinoprost Tromethamine—PTGER1—central nervous system—amyotrophic lateral sclerosis	0.00594	0.0358	CbGeAlD
Dinoprost Tromethamine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0104	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00559	0.0104	CcSEcCtD
Dinoprost Tromethamine—HPGDS—spinal cord—amyotrophic lateral sclerosis	0.00555	0.0334	CbGeAlD
Dinoprost Tromethamine—PTGER3—nervous system—amyotrophic lateral sclerosis	0.00541	0.0326	CbGeAlD
Dinoprost Tromethamine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0054	0.01	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—brain—amyotrophic lateral sclerosis	0.00537	0.0323	CbGeAlD
Dinoprost Tromethamine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00991	CcSEcCtD
Dinoprost Tromethamine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00524	0.00972	CcSEcCtD
Dinoprost Tromethamine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00521	0.00967	CcSEcCtD
Dinoprost Tromethamine—PTGER3—central nervous system—amyotrophic lateral sclerosis	0.00521	0.0314	CbGeAlD
Dinoprost Tromethamine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00511	0.00947	CcSEcCtD
Dinoprost Tromethamine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00507	0.00941	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00934	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00502	0.00931	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00495	0.00918	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00489	0.00907	CcSEcCtD
Dinoprost Tromethamine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00471	0.00874	CcSEcCtD
Dinoprost Tromethamine—HPGDS—nervous system—amyotrophic lateral sclerosis	0.00468	0.0281	CbGeAlD
Dinoprost Tromethamine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00467	0.00866	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00859	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00459	0.0085	CcSEcCtD
Dinoprost Tromethamine—PTGIR—spinal cord—amyotrophic lateral sclerosis	0.00452	0.0272	CbGeAlD
Dinoprost Tromethamine—HPGDS—central nervous system—amyotrophic lateral sclerosis	0.0045	0.0271	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—medulla oblongata—amyotrophic lateral sclerosis	0.00448	0.027	CbGeAlD
Dinoprost Tromethamine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00443	0.00822	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00426	0.0079	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00784	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00422	0.00782	CcSEcCtD
Dinoprost Tromethamine—PTGER3—brain—amyotrophic lateral sclerosis	0.00413	0.0249	CbGeAlD
Dinoprost Tromethamine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00752	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—spinal cord—amyotrophic lateral sclerosis	0.00399	0.024	CbGeAlD
Dinoprost Tromethamine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00725	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00719	CcSEcCtD
Dinoprost Tromethamine—PTGIR—nervous system—amyotrophic lateral sclerosis	0.00381	0.0229	CbGeAlD
Dinoprost Tromethamine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00695	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00695	CcSEcCtD
Dinoprost Tromethamine—PTGIR—central nervous system—amyotrophic lateral sclerosis	0.00367	0.0221	CbGeAlD
Dinoprost Tromethamine—PTGIR—cerebellum—amyotrophic lateral sclerosis	0.00359	0.0216	CbGeAlD
Dinoprost Tromethamine—HPGDS—brain—amyotrophic lateral sclerosis	0.00357	0.0215	CbGeAlD
Dinoprost Tromethamine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00648	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00631	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—nervous system—amyotrophic lateral sclerosis	0.00336	0.0203	CbGeAlD
Dinoprost Tromethamine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00622	CcSEcCtD
Dinoprost Tromethamine—SLCO2A1—nervous system—amyotrophic lateral sclerosis	0.00333	0.0201	CbGeAlD
Dinoprost Tromethamine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00602	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—central nervous system—amyotrophic lateral sclerosis	0.00324	0.0195	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—central nervous system—amyotrophic lateral sclerosis	0.00321	0.0193	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—cerebellum—amyotrophic lateral sclerosis	0.00317	0.0191	CbGeAlD
Dinoprost Tromethamine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00582	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00559	CcSEcCtD
Dinoprost Tromethamine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00555	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00299	0.00554	CcSEcCtD
Dinoprost Tromethamine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00551	CcSEcCtD
Dinoprost Tromethamine—PTGIR—brain—amyotrophic lateral sclerosis	0.00291	0.0175	CbGeAlD
Dinoprost Tromethamine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00523	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—brain—amyotrophic lateral sclerosis	0.00277	0.0167	CbGeAlD
Dinoprost Tromethamine—SLC22A6—brain—amyotrophic lateral sclerosis	0.00268	0.0161	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—brain—amyotrophic lateral sclerosis	0.00257	0.0155	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—brain—amyotrophic lateral sclerosis	0.00255	0.0153	CbGeAlD
Dinoprost Tromethamine—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.0021	0.0126	CbGeAlD
Dinoprost Tromethamine—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.00202	0.0121	CbGeAlD
Dinoprost Tromethamine—Tafluprost—PTGS2—amyotrophic lateral sclerosis	0.00191	1	CrCbGaD
Dinoprost Tromethamine—SLC22A8—brain—amyotrophic lateral sclerosis	0.0016	0.00964	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000949	0.00324	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000947	0.00324	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000941	0.00322	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000936	0.0032	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00093	0.00318	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000928	0.00317	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000914	0.00312	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000901	0.00308	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.0009	0.00308	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000884	0.00302	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—DAO—amyotrophic lateral sclerosis	0.000881	0.00301	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000878	0.003	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000859	0.00293	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000856	0.00293	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000844	0.00289	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000842	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00084	0.00287	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00084	0.00287	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000832	0.00284	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000828	0.00283	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000818	0.0028	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000803	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000796	0.00272	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000781	0.00267	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000758	0.00259	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000741	0.00253	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000738	0.00252	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000735	0.00251	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00073	0.00249	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000719	0.00246	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000717	0.00245	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000709	0.00242	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000703	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000691	0.00236	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000683	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000683	0.00234	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000668	0.00228	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000664	0.00227	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000658	0.00225	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000657	0.00224	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000653	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000651	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000649	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000637	0.00218	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000627	0.00214	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000624	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000617	0.00211	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—GSR—amyotrophic lateral sclerosis	0.000616	0.00211	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000616	0.00211	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000616	0.0021	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000609	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000597	0.00204	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000592	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000589	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000585	0.002	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000567	0.00194	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000566	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000563	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000562	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000561	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000556	0.0019	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000554	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00053	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00053	0.00181	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000523	0.00179	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000523	0.00179	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000514	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000509	0.00174	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000506	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000503	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000501	0.00171	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000498	0.0017	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000494	0.00169	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000492	0.00168	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000485	0.00166	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000484	0.00166	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000482	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000482	0.00165	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000481	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000481	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000479	0.00164	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000476	0.00163	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000475	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000475	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000473	0.00162	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000466	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000462	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000459	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000454	0.00155	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000451	0.00154	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000441	0.00151	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00044	0.0015	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000432	0.00148	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000431	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000431	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000429	0.00147	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000416	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000414	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000409	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000405	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000404	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000404	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000397	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000396	0.00136	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00039	0.00133	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000386	0.00132	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000382	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000375	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000371	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000368	0.00126	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000367	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000367	0.00125	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00036	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000352	0.0012	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000348	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000343	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000342	0.00117	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000338	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000338	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000336	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000336	0.00115	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000331	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000323	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000323	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000321	0.0011	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000317	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000317	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000316	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000316	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000316	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000314	0.00107	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000306	0.00105	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000305	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000301	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.0003	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.0003	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000296	0.00101	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000291	0.000995	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00029	0.000992	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00029	0.000992	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00029	0.000992	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000285	0.000975	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000283	0.000968	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000281	0.000962	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000281	0.000962	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000272	0.00093	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00027	0.000923	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000265	0.000906	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000263	0.0009	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000261	0.000894	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00026	0.00089	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000258	0.000881	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000258	0.000881	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000257	0.000879	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000255	0.000871	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000255	0.000871	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000254	0.000867	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000252	0.000863	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000251	0.000857	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00025	0.000854	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.00025	0.000853	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000249	0.00085	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000246	0.00084	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000239	0.000818	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000237	0.00081	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000229	0.000784	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000224	0.000767	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000218	0.000744	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000217	0.000743	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000214	0.00073	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000213	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000213	0.000728	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000212	0.000724	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000207	0.000709	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000207	0.000709	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—APOE—amyotrophic lateral sclerosis	0.000206	0.000703	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000203	0.000693	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000202	0.000691	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000192	0.000657	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000191	0.000652	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000189	0.000645	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000188	0.000643	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000188	0.000643	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000183	0.000625	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000179	0.000611	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000175	0.000598	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000175	0.000598	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000174	0.000595	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000172	0.000588	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000168	0.000576	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000168	0.000573	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000167	0.000571	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000165	0.000563	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000164	0.000561	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000164	0.000561	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00016	0.000549	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00016	0.000546	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000157	0.000536	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000156	0.000534	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000156	0.000534	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000152	0.000519	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000141	0.000484	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000141	0.000482	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000137	0.000467	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000134	0.000457	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000134	0.000457	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000132	0.000451	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.00013	0.000443	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000129	0.00044	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000129	0.000439	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.00043	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.00043	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000125	0.000426	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000122	0.000416	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000117	0.0004	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000114	0.000388	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000111	0.00038	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000111	0.00038	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000109	0.000373	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000106	0.000362	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000104	0.000354	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000104	0.000354	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.97e-05	0.000341	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.42e-05	0.000322	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9e-05	0.000308	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.74e-05	0.000299	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.55e-05	0.000292	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.55e-05	0.000292	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.5e-05	0.000291	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.46e-05	0.000289	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.25e-05	0.000282	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.63e-05	0.000261	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.08e-05	0.000242	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.73e-05	0.00023	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.58e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.58e-05	0.000225	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.51e-05	0.000223	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.39e-05	0.000219	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.36e-05	0.000217	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.22e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.22e-05	0.000213	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.77e-05	0.000197	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.71e-05	0.000195	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.59e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.59e-05	0.000191	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.36e-05	0.000183	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.31e-05	0.000147	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.22e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.22e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.67e-05	0.000125	CbGpPWpGaD
